Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(1):42-48
This article describes clinical development stages for the novel anti-TB drug «Perchlozone®», which has been approved in Russian Federation in 2012. Based on the phase I–III clinical studies results, efficacy and safety of the drug were assessed, and …